Sakar Healthcare Limited (NSE:SAKAR)
India · Delayed Price · Currency is INR 892.80
+48.40 (5.73%)
Jul 31, 2026, 3:30 PM IST
Sakar Healthcare Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 304.85 | 175.02 | 116.71 | 127.59 | 152.43 |
Depreciation & Amortization | 235.65 | 199.72 | 179.54 | 149.86 | 73.28 |
Other Amortization | 0.58 | 9.68 | 1.55 | 0.58 | 7.3 |
Loss (Gain) From Sale of Assets | - | 3.39 | - | - | - |
Loss (Gain) From Sale of Investments | - | - | 2.94 | -1.27 | - |
Provision & Write-off of Bad Debts | 0.35 | - | - | - | - |
Other Operating Activities | 124.1 | 93.31 | 75.77 | 50.71 | 38.84 |
Change in Accounts Receivable | -193.95 | -98.32 | 11.49 | -79.09 | -41.43 |
Change in Inventory | -264.49 | -158.6 | -123.35 | -12.14 | -4.76 |
Change in Accounts Payable | 304.73 | -63.87 | 13.65 | -44.16 | 25.9 |
Change in Other Net Operating Assets | -19.23 | 179.99 | -33.62 | 141.36 | -5.17 |
Operating Cash Flow | 492.58 | 340.32 | 244.67 | 333.44 | 246.38 |
Operating Cash Flow Growth | 44.74% | 39.09% | -26.62% | 35.34% | 69.02% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -283.52 | -322.83 | -595.6 | -821.95 | -355.46 |
Investment in Securities | - | - | 31.35 | 38.04 | - |
Other Investing Activities | - | 15.73 | 48.86 | 40.15 | -112.88 |
Investing Cash Flow | -283.52 | -307.09 | -515.39 | -743.77 | -468.33 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | - | - | - | 132.21 | 280.16 |
Short-Term Debt Repaid | - | - | - | - | -19.62 |
Long-Term Debt Repaid | -222.41 | -13.61 | -432.73 | - | - |
Total Debt Repaid | -222.41 | -13.61 | -432.73 | - | -19.62 |
Net Debt Issued (Repaid) | -222.41 | -13.61 | -432.73 | 132.21 | 260.54 |
Issuance of Common Stock | 86.4 | 76.8 | 726.2 | 333.5 | 78.84 |
Other Financing Activities | -73.54 | -97.98 | -19.02 | -54.75 | -19.05 |
Financing Cash Flow | -209.56 | -34.79 | 274.45 | 410.96 | 320.33 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | 0 | -0 | 0 | -101.04 |
Net Cash Flow | -0.5 | -1.56 | 3.72 | 0.64 | -2.66 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 209.06 | 17.5 | -350.93 | -488.51 | -109.08 |
Free Cash Flow Growth | 1094.96% | - | - | - | - |
Free Cash Flow Margin | 8.30% | 0.98% | -22.76% | -36.40% | -8.45% |
Free Cash Flow Per Share | 9.39 | 0.80 | -16.93 | -26.27 | -7.24 |
Levered Free Cash Flow | 68.57 | -192.36 | -499.42 | -735.17 | -156.55 |
Unlevered Free Cash Flow | 117.09 | -143.58 | -457.84 | -701.45 | -140.38 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 72.97 | 78.21 | 66.45 | 54.17 | 19.05 |
Cash Income Tax Paid | 40.09 | 23.74 | 31.52 | 42.66 | 7.26 |
Change in Working Capital | -172.94 | -140.8 | -131.83 | 5.97 | -25.46 |